Gene: SCART1
Official Full Name: scavenger receptor family member expressed on T cells 1provided by HGNC
Gene Summary: Predicted to be involved in T cell mediated immunity. Located in brush border and cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14314 | SCART1 Knockout cell line (HeLa) | Human | SCART1 | 1:3~1:6 | Negative | Online Inquiry |
KO14315 | SCART1 Knockout cell line (HCT 116) | Human | SCART1 | 1:2~1:4 | Negative | Online Inquiry |
KO14316 | SCART1 Knockout cell line (A549) | Human | SCART1 | 1:3~1:4 | Negative | Online Inquiry |
SCART1 Gene Knockout Cell Lines are specifically engineered cellular models designed to facilitate the study of the SCART1 gene's functions and the role it plays in various biological processes. By utilizing CRISPR-Cas9 genome editing technology, these cell lines exhibit a precise knockout of the SCART1 gene, allowing researchers to investigate the downstream effects of its absence. This technique permits targeted disruption, enabling a deeper understanding of gene function and the molecular pathways in which SCART1 is involved.
The primary mechanism of these cell lines revolves around their ability to model the genetic loss of SCART1, a gene implicated in immune responses and cellular signaling. Researchers can assess changes in cellular behavior, such as proliferation, apoptosis, and differential gene expression, which may provide insights into the gene's role in health and disease, including autoimmune disorders and inflammation. This mechanism is particularly valuable in elucidating the perturbations that arise when SCART1 is absent, thus offering a channel to identify potential therapeutic targets.
Scientific importance lies in the application of SCART1 Gene Knockout Cell Lines in both fundamental and translational research. These lines can be utilized to screen compounds for potential therapeutic effects, study immune system dynamics, and develop novel interventions for diseases where SCART1 plays a critical role. Their relevance is underscored by the growing need for precise biological models that replicate human disease mechanisms.
What sets our SCART1 Gene Knockout Cell Lines apart from alternative products is their robustness and reliability, having undergone rigorous validation processes to ensure consistent performance across laboratory settings. Unlike transient transfection methods, which may produce heterogeneous populations, these knockout cell lines provide a stable and uniform genetic background, enabling reproducible results in experiments.
For researchers and clinicians, the ability to dissect the role of SCART1 in a controlled environment offers unique insights that can accelerate the pace of scientific discovery. These cell lines empower users to effectively investigate complex biological pathways, enhancing the development of innovative therapeutic strategies.
As a company dedicated to advancing research in the life sciences, we pride ourselves on delivering high-quality, scientifically validated model systems like SCART1 Gene Knockout Cell Lines. Our expertise in cellular engineering ensures that we provide researchers with the tools necessary to drive breakthroughs in their investigations, supporting advancements in both academic and clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.